Are primate models of neuropsychiatric disorders useful to the pharmaceutical industry?
D000818:Animals; D003362:Cost-Benefit Analysis; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D006801:Humans; D001523:Mental Disorders; D009422:Nervous System Diseases; D011323:Primates; D013045:Species Specificity